Well, now you don't have to look any farther than Columbus, Ohio, where researchers from the Wexner Medical Center at the Ohio State University have developed a device capable of repairing organs with a single touch.
Another test involved injecting new nerve cells into a mouse's brain to enable it to recover from a stroke. After a week, the new cells formed new blood vessels and nerve tissue.
Within a week, active blood vessels appeared in the injured leg, and by the second week, the leg was saved.
In less than a second, this chip would deliver reprogramming factors (pre-programmed DNA or RNA) non-invasively into living skin cells via a high-intensity, focused electric field, converting them into whatever type of cells a scientist or doctor may choose.
In what is seen as a breakthrough in the field of regenerative medicine, Indian-origin researcher in the United States developed a technology that can fix organs, blood vessels and nerves by a single touch.
Researchers have developed a tiny chip that, when applied to an affected area, can regenerate and fix failing body functions by turning skin cells into other types of healing cells. It simply involves the chip being placed on the skin and a light electrical current applied, which patients barely feel. "We have shown that skin is a fertile land where we can grow the elements of any organ that is declining".
This breakthrough technology is the first time cells have been reprogrammed in a live body.In the study, researchers were able to reprogram skin cells to become vascular cells in badly injured legs that lacked blood flow. Through this process, the DNA will be converted to the specific building block cells of the damaged body part. What they did was they used the TNT to grow brain cells on the mouse's skin.
The concept is very simple, adds co-author James Lee: "As a matter of fact, we were even surprised how it worked so well".
"By using our novel nanochip technology, injured or compromised organs can be replaced".
TNT doesn't require any laboratory-based procedures and may be implemented at the point of care. In my lab, we have ongoing research trying to understand the mechanism and do even better.
Since the method uses a patient's own cells and does not depend upon medication, the Researchers anticipate it to be approved for human trials by the end of the year.